Medicare Enrolled

Dr. Surekha Gangasani, M.D.

Rheumatology · McKinney, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1445 HERITAGE DR, McKinney, TX 75069
9725479700
In practice since 2006 (19 years)
NPI: 1437255619 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gangasani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gangasani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gangasani

Dr. Surekha Gangasani is a rheumatology in McKinney, TX, with 19 years in practice. Based on federal Medicare data, Dr. Gangasani performed 4,731 Medicare services across 619 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gangasani received a total of $11,173 from 45 pharmaceutical and/or device companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gangasani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 44% volume in TX$ $11,173 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,731
Medicare services
Top 44% in TX for rheumatology
619
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~249 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)3,480$18$50
Office visit, established patient (30-39 min)437$88$300
Office visit, established patient (20-29 min)214$59$200
Steroid injection (triamcinolone)120$1$10
Administration of chemotherapy into vein, each additional hour112$21$150
Administration of chemotherapy into vein, 1 hour or less79$94$350
Infusion, normal saline solution, 250 cc79$1$20
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle70$54$190
New patient office visit (45-59 min)59$114$430
Drug injection, under skin or into muscle41$10$70
Joint injection, major joint29$50$160
New patient office visit (30-44 min)11$63$280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
83.1% medium
15.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,173
Total received (2018-2024)
Avg $1,596/year across 7 years
Top 31% in TX for rheumatology
45
Companies
495
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,345 (74.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,828 (25.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,937
2023
$1,612
2022
$846
2021
$806
2020
$888
2019
$3,740
2018
$1,344

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Horizon Therapeutics plc
$2,740
Amgen Inc.
$1,957
PFIZER INC.
$783
Novartis Pharmaceuticals Corporation
$610
ABBVIE INC.
$600
Janssen Biotech, Inc.
$525
Genentech USA, Inc.
$476
Lilly USA, LLC
$405
GlaxoSmithKline, LLC.
$394
AbbVie, Inc.
$321
Mallinckrodt Hospital Products Inc.
$274
UCB, Inc.
$222
AstraZeneca Pharmaceuticals LP
$217
Boehringer Ingelheim Pharmaceuticals, Inc.
$217
AbbVie Inc.
$202
Janssen Scientific Affairs, LLC
$142
GENZYME CORPORATION
$135
E.R. Squibb & Sons, L.L.C.
$132
Radius Health, Inc.
$127
Hikma Pharmaceuticals USA
$59
Celgene Corporation
$54
Mallinckrodt Enterprises LLC
$50
Organon LLC
$41
DePuy Synthes Sales Inc.
$41
BIOTRONIK NRO, Inc.
$41
Sandoz Inc.
$35
Alexion Pharmaceuticals, Inc.
$35
ANI Pharmaceuticals, Inc.
$31
Fresenius Kabi USA, LLC
$31
Horizon Pharma plc
$25
SCILEX PHARMACEUTICALS INC.
$21
Bioventus LLC
$20
ARBOR PHARMACEUTICALS, INC.
$19
Ferring Pharmaceuticals Inc.
$19
Flexion Therapeutics, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Ultragenyx Pharmaceutical Inc.
$17
Sobi, Inc
$17
Aurinia Pharma U.S., Inc.
$17
Exeltis, USA Inc.
$16
Teva Pharmaceuticals USA, Inc.
$16
Abbott Laboratories
$13
SOBI, INC
$13
Antares Pharma, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 49.0% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BEXSERO · BIOTRONIK · COSENTYX · CYLTEZO · Cimzia · Durolane · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · Horizant · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · ORENCIA · ORTHOVISC · Otezla · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STRENSIQ · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ · XIFIXAN · XYOSTED · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $236 per 100 Medicare services performed
Looking for a rheumatology in McKinney?
Compare rheumatologys in the McKinney area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
56
Per 100K population
5.0
County median income
$117,588
Nearest hospital
MEDICAL CENTER OF MCKINNEY
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gangasani is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gangasani experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Gangasani performed 3,480 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gangasani receive payments from pharmaceutical companies?
Yes. Dr. Gangasani received a total of $11,173 from 45 companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gangasani's costs compare to other rheumatologys in McKinney?
Dr. Gangasani's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gangasani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →